Pharmacology Watch – September 1, 2016
September 1, 2016
View Issues
-
Top Pharmaceutical Company Suffers Blow After Major Drug Fails Phase III Trial
The checkpoint inhibitor nivolumab failed a Phase III trial as monotherapy in patients with previously untreated non-small cell lung cancer.
-
Report: Certain Drugs Cause, Exacerbate Heart Failure
New recommendations for clinicians treating heart failure patients include comprehensive medication reconciliation, evaluating risks and benefits of every medication, and discontinuing medications when possible.
-
Study: Knee Replacement Can Lead to Chronic Opioid Use
Total knee replacement is the surgical procedure most commonly associated with chronic opioid use in opioid-naïve patients.
-
FDA Actions
In this section: FDA approves generic influenza treatment; major pharma loses statin battle; FDA gives thumbs up to agonist to treat type 2 diabetes; agency green lights dry eye disease solution; and approves over-the-counter acne treatment.